
Grace Therapeutics
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2 | -4 | ||
EBITDA | -2,138 | -15,788 | -3,008 | -3,357 |
EBIT | -2,139 | -15,790 | -3,010 | -3,360 |
Net Income | -2,131 | -15,790 | -1,178 | -3,176 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,784 | -3,221 | -1,706 | -2,218 |
Cash | 21,311 | 13,756 | 16,977 | 18,672 |
Basic Shares | 20,116 | 17,269 | 16,510 | 16,933 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -7 | -11 | -124 |
EBITDA | -11,070 | -23,745 | -15,414 | -24,555 |
EBIT | -11,077 | -23,752 | -15,425 | -24,679 |
Net Income | -7,793 | -13,625 | -17,441 | -57,386 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,869 | -14,904 | -12,355 | -15,930 |
Cash | 16,977 | 22,133 | 23,005 | 27,875 |
Basic Shares | 16,510 | 12,087 | 9,529 | 7,435 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.11 |
2026-06-30 | -$0.91 |
2026-03-31 | -$0.08 |
2025-12-31 | -$0.19 |